Condition
Peripheral Arterial Disease
Peripheral arterial disease happens when narrowed arteries, usually from atherosclerosis, reduce blood flow to the legs, often causing cramping pain when walking. The evidence is strongest for L-carnitine, though trials mostly showed blood carnitine levels went up, and blood flow went up with cocoa extract in limited research. The cocoa studies involved few people, and omega-3 showed no clear difference in blood flow.
Sources: PMID 21807659; PMID 16702322; PMID 8063466
- Supplements studied
- 9
- Graded outcomes
- 8
- Trials
- 16
- People studied
- 2,629
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Carnitine Large Increase | Improves (the measure goes up) | Large effect | 2 studies | 7 people | ||
| Blood Lactate (Exercise) | Changes; see studies | 5 studies | 63 people | |||
Studies that measured blood lactate (exercise)
| ||||||
| Intermittent Claudication Symptoms | Improves (the measure goes down) | 3 studies | 62 people | |||
Studies that measured intermittent claudication symptoms | ||||||
| Peripheral Vascular Disease Symptoms | Improves (the measure goes down) | 2 studies | 82 people | |||
Studies that measured peripheral vascular disease symptoms
| ||||||
| Peak flow time | Improves (the measure goes up) | 1 study | 12 people | |||
Studies that measured peak flow time | ||||||
| Blood Flow | Improves (the measure goes up) | 68 people | ||||
| Hyperemia | Improves (the measure goes up) | 12 people | ||||
| Lung Function | Improves (the measure goes up) | 7 people | ||||
| Quality of Life | Improves (the measure goes up) | 62 people | ||||
| Strength | Improves (the measure goes up) | 7 people | ||||
| Walking Ability | Improves (the measure goes up) | 151 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Moderate Increase | Improves (the measure goes up) | Moderate effect | 2 studies | 43 people | ||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 2 studies | 22 people | |||
Studies that measured oxidative stress biomarkers | ||||||
| Peripheral Vascular Disease Symptoms | Improves (the measure goes down) | 2 studies | 43 people | |||
Studies that measured peripheral vascular disease symptoms | ||||||
| Nitric Oxide | Improves (the measure goes up) | 43 people | ||||
Resveratrol
- Intercellular Adhesion Molecule 1: improves
- Vascular Function: improves
- Plasminogen Inhibitor-1: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Intercellular Adhesion Molecule 1 Small Decrease | Improves (the measure goes down) | Small effect | 1,034 people | |||
| Vascular Function | Improves (the measure goes up) | 2 studies | 1,034 people | |||
Studies that measured vascular function
| ||||||
| Plasminogen Inhibitor-1 | Improves (the measure goes up) | 1,034 people | ||||
Fish Oil
- C-Reactive Protein (CRP)
- Inflammation: improves
- Platelet Aggregation: changes; see studies
Alpha-Lipoic Acid
- C-Reactive Protein (CRP)
- Intermittent Claudication Symptoms: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 2 studies | 28 people | |||
Studies that measured c-reactive protein (crp) | ||||||
| Intermittent Claudication Symptoms | Changes; see studies | 28 people | ||||
Arginine
- Asymmetric dimethylarginine (aka ADMA)
- Nitric Oxide: improves
- Plasma Arginine: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Asymmetric dimethylarginine (aka ADMA) No effect | NoneNo effect | 133 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 4 studies | 38 people | |||
Studies that measured nitric oxide
| ||||||
| Plasma Arginine | Improves (the measure goes up) | 2 studies | 133 people | |||
| Blood Flow | Improves (the measure goes up) | 1 study | 133 people | |||
| Blood glucose | Changes; see studies | 1 study | 38 people | |||
Studies that measured blood glucose | ||||||
| Oxidative Stress Biomarkers | Changes; see studies | 1 study | 38 people | |||
| HbA1c | Changes; see studies | 38 people | ||||
| Intermittent Claudication Symptoms | Changes; see studies | 133 people | ||||
| Subjective Well-Being | Improves (the measure goes up) | 133 people | ||||
Ginkgo Biloba
- Apolipoprotein B
- Intermittent Claudication Symptoms: improves
- Blood Flow: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein B No effect | NoneNo effect | 62 people | ||||
| Intermittent Claudication Symptoms | Improves (the measure goes down) | 5 studies | 161 people | |||
Studies that measured intermittent claudication symptoms
| ||||||
| Blood Flow | Improves (the measure goes up) | 2 studies | 62 people | |||
Studies that measured blood flow | ||||||
| LDL Oxidation | Improves (the measure goes down) | 62 people | ||||
Omega-3 Fatty Acids
- Blood Flow
- Walking Ability: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow No effect | NoneNo effect | 206 people | ||||
| Walking Ability | Improves (the measure goes up) | 1 study | 122 people | |||
Policosanol
- Intermittent Claudication Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Intermittent Claudication Symptoms | Improves (the measure goes down) | 1 study | 56 people | |||
Studies that measured intermittent claudication symptoms | ||||||
Key findings
- Blood CarnitineImproves (the measure goes up)
- Blood FlowImproves (the measure goes up)
- Intercellular Adhesion Molecule 1Improves (the measure goes down)
The Peripheral Arterial Disease (PAD) Support protocol
2 primary supplements · 6 supporting supplements
- L-Carnitine / Propionyl-L-Carnitine1–2 g L-carnitine or 500–1,000 mg propionyl-L-carnitine twice daily
- Omega-3 Fatty Acids2–4 g EPA+DHA daily
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Peripheral Arterial Disease. If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
1 study from PubMed